SEC Form 4 · accession 0001225208-17-016030

BOSTON SCIENTIFIC CORP · BSX

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

Supratim Bose

Officer — EVP & President, Asia-Pacific

Period of report

Oct 3, 2017

Accepted (ET)

Oct 5, 2017 · 4:16 pm EDT

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0000885725

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I
Common Stock	Oct 3, 2017	M	174,672	$5.36	A	494,973	D
Common Stock	Oct 3, 2017	M	22,145	$6.28	A	517,118	D
Common Stock^F2	Oct 3, 2017	S	196,817	$29.0789	D	320,301	D
Common Stock	Oct 4, 2017	M	88,071	$7.39	A	408,372	D
Common Stock	Oct 4, 2017	M	23,907	$13.08	A	432,279	D
Common Stock	Oct 4, 2017	M	15,352	$6.28	A	447,631	D
Common Stock	Oct 4, 2017	M	15,086	$16.31	A	462,717	D
Common Stock	Oct 4, 2017	M	7,904	$17.26	A	470,621	D
Common Stock^F3	Oct 4, 2017	S	150,320	$29.18	D	320,301	D

Table II — derivative securities

Security	Conv. / exercise price	Date	Code	Shares	A/D	Exercisable	Expires	Underlying	Underlying shares	Owned after	D/I
Stock Option (Right to Buy)^F4	$5.36	Oct 3, 2017	M	174,672	D	—	Jan 3, 2022	Common Stock	174,672	0	D
Stock Option (Right to Buy)^F5	$6.28	Oct 3, 2017	M	22,145	D	—	Feb 27, 2022	Common Stock	22,145	15,352	D
Stock Option (Right to Buy)^F6	$17.26	Oct 4, 2017	M	7,904	D	—	Feb 22, 2026	Common Stock	7,904	23,714	D
Stock Option (Right to Buy)^F7	$16.31	Oct 4, 2017	M	15,086	D	—	Feb 23, 2025	Common Stock	15,086	15,086	D
Stock Option (Right to Buy)^F8	$13.08	Oct 4, 2017	M	23,907	D	—	Feb 24, 2024	Common Stock	23,907	7,969	D
Stock Option (Right to Buy)^F5	$6.28	Oct 4, 2017	M	15,352	D	—	Feb 27, 2022	Common Stock	15,352	0	D
Stock Option (Right to Buy)^F9	$7.39	Oct 4, 2017	M	88,071	D	—	Feb 28, 2023	Common Stock	88,071	0	D

Explanation of responses

F1The transactions reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan.
F2Represents the weighted average sale price. These shares were sold in multiple transactions at prices ranging from $29.00 to $29.4901, inclusive. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
F3Represents the weighted average sale price. These shares were sold in multiple transactions at prices ranging from $29.07 to $29.255, inclusive. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
F4Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in four equal annual installments beginning on January 3, 2013, the first anniversary of the grant.
F5Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in four equal annual installments beginning on February 27, 2013, the first anniversary of the date of grant.
F6Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in four equal annual installments beginning on February 22, 2017, the first anniversary of the date of grant.
F7Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in four equal annual installments beginning on February 23, 2016, the first anniversary of the date of grant.
F8Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in four equal annual installments beginning on February 24, 2015, the first anniversary of the date of grant.
F9Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in four equal annual installments beginning on February 28, 2014, the first anniversary of the date of grant.